Cargando…
Agonistic Anti-TIGIT Treatment Inhibits T Cell Responses in LDLr Deficient Mice without Affecting Atherosclerotic Lesion Development
OBJECTIVE: Co-stimulatory and co-inhibitory molecules are mainly expressed on T cells and antigen presenting cells and strongly orchestrate adaptive immune responses. Whereas co-stimulatory molecules enhance immune responses, signaling via co-inhibitory molecules dampens the immune system, thereby s...
Autores principales: | Foks, Amanda C., Ran, Ingrid A., Frodermann, Vanessa, Bot, Ilze, van Santbrink, Peter J., Kuiper, Johan, van Puijvelde, Gijs H. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869776/ https://www.ncbi.nlm.nih.gov/pubmed/24376654 http://dx.doi.org/10.1371/journal.pone.0083134 |
Ejemplares similares
-
Stimulation of the PD-1 Pathway Decreases Atherosclerotic Lesion Development in Ldlr Deficient Mice
por: Grievink, Hendrika W., et al.
Publicado: (2021) -
Blockade of the BLT1-LTB(4) axis does not affect mast cell migration towards advanced atherosclerotic lesions in LDLr(−/−) mice
por: Depuydt, Marie A. C., et al.
Publicado: (2022) -
Defective Autophagy in T Cells Impairs the Development of Diet-Induced Hepatic Steatosis and Atherosclerosis
por: Amersfoort, Jacob, et al.
Publicado: (2018) -
Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice
por: Kritikou, Eva, et al.
Publicado: (2016) -
Mesenchymal Stem Cells Reduce Murine Atherosclerosis Development
por: Frodermann, Vanessa, et al.
Publicado: (2015)